Literature DB >> 4195769

Extraskeletal calcification complicating oral neutral-phosphate therapy.

F J Dudley, C R Blackburn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4195769     DOI: 10.1016/s0140-6736(70)91398-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 2.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

3.  Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.

Authors:  W C Thomas
Journal:  Trans Am Clin Climatol Assoc       Date:  1972

4.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

5.  Calcium free hemodialysis: an effective therapy in hypercalcemic crisis--report of 4 cases.

Authors:  W Kaiser; G Biesenbach; R Kramar; J Zazgornik
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 6.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism.

Authors:  T Gibson; H P Sims; S A Jimenez
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

8.  Progressive renal failure in surgically treated hyperparathyroidism.

Authors:  J Dixon; J F Smith
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

9.  Hypercalcaemia. What does it signify?

Authors:  R A Evans
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

Review 10.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.

Authors:  Eliot C Heher; Samuel O Thier; Helmut Rennke; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.